0001209191-19-061778.txt : 20191223
0001209191-19-061778.hdr.sgml : 20191223
20191223161140
ACCESSION NUMBER: 0001209191-19-061778
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191219
FILED AS OF DATE: 20191223
DATE AS OF CHANGE: 20191223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WOODS RANDALL E
CENTRAL INDEX KEY: 0001196862
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36054
FILM NUMBER: 191306126
MAIL ADDRESS:
STREET 1: C/O ARENA PHARMACEUTICALS, INC.
STREET 2: 6166 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOPHIRIS BIO INC.
CENTRAL INDEX KEY: 0001563855
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1258 PROSPECT STREET
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-777-1760
MAIL ADDRESS:
STREET 1: 1258 PROSPECT STREET
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-19
0
0001563855
SOPHIRIS BIO INC.
SPHS
0001196862
WOODS RANDALL E
1258 PROSPECT STREET
LA JOLLA
CA
92037
1
1
0
0
President & Chief Exec Officer
Common Stock (Right to Buy)
0.36
2019-12-19
4
A
0
175000
0.36
A
2020-12-19
2029-12-18
Common Stock
175000
175000
D
33% of the shares subject to the option shall vest one year after the date of grant. The remainder shall vest monthly thereafter over the next two years until fully vested on December 19, 2022.
Peter Slover, Attorney-In-Fact
2019-12-23